CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma
Authors
Keywords
-
Journal
MOLECULAR THERAPY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-09-02
DOI
10.1016/j.ymthe.2022.08.021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineered T Cells: CAR T Cell Therapy and Beyond
- (2022) P. Connor Johnson et al. Current Oncology Reports
- Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma
- (2022) Wenqing Gao et al. Journal of Inflammation Research
- Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
- (2021) Nicholas A. Vitanza et al. NATURE MEDICINE
- CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
- (2021) Luke Maggs et al. Frontiers in Neuroscience
- T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours
- (2021) Stefanie Lesch et al. Nature Biomedical Engineering
- A review of glioblastoma immunotherapy
- (2020) Ravi Medikonda et al. JOURNAL OF NEURO-ONCOLOGY
- Management of glioblastoma: State of the art and future directions
- (2020) Aaron C. Tan et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study
- (2020) Dmitriy Zamarin et al. CLINICAL CANCER RESEARCH
- Immune suppression in gliomas
- (2020) Matthew M. Grabowski et al. JOURNAL OF NEURO-ONCOLOGY
- Cytokine and Chemokine Signals of T-Cell Exclusion in Tumors
- (2020) Yu Zhang et al. Frontiers in Immunology
- Myeloid Cells in Glioblastoma Microenvironment
- (2020) Alessandra De Leo et al. Cells
- Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
- (2019) William Tomaszewski et al. CLINICAL CANCER RESEARCH
- Optimizing oncolytic virotherapy in cancer treatment
- (2019) Kevin Harrington et al. NATURE REVIEWS DRUG DISCOVERY
- Adenovirus Entry: From Infection to Immunity
- (2019) Urs F. Greber et al. Annual Review of Virology
- Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
- (2018) Donatella Aldinucci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
- (2018) Jhajaira M. Araujo et al. Scientific Reports
- CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
- (2018) Santosh Kumar Singh et al. Scientific Reports
- CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer
- (2018) Asim Pervaiz et al. CELLULAR ONCOLOGY
- A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer
- (2017) Chiara Berlato et al. JOURNAL OF CLINICAL INVESTIGATION
- Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells
- (2016) Ann Ager et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Cancer Cell Dissemination and Homing to the Bone Marrow in a Zebrafish Model
- (2016) Antonio Sacco et al. CANCER RESEARCH
- Erratum: Oncolytic viruses: a new class of immunotherapy drugs
- (2016) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- CXCR3 ligands in disease and therapy
- (2015) Katrien Van Raemdonck et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3
- (2015) Mahiuddin Ahmed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemokines in tumor progression and metastasis
- (2015) Purvaba J. Sarvaiya et al. Oncotarget
- Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor-Modified T Cells in Solid Tumors
- (2014) N. Nishio et al. CANCER RESEARCH
- Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor-Transduced Human T cells in Solid Tumors
- (2014) E. K. Moon et al. CLINICAL CANCER RESEARCH
- CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model
- (2014) Steve Oghumu et al. IMMUNOLOGY
- Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells
- (2014) S. Matsumura et al. JOURNAL OF IMMUNOLOGY
- Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
- (2014) Zong Sheng Guo et al. Frontiers in Oncology
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
- (2012) I. Diaconu et al. CANCER RESEARCH
- A review on CXCR4/CXCL12 axis in oncology: No place to hide
- (2012) Urszula M. Domanska et al. EUROPEAN JOURNAL OF CANCER
- Tumor associated macrophages and neutrophils in tumor progression
- (2012) Maria R. Galdiero et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
- (2011) M. Hong et al. CANCER RESEARCH
- Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
- (2011) E. K. Moon et al. CLINICAL CANCER RESEARCH
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer
- (2009) Bernhard Mlecnik et al. GASTROENTEROLOGY
- The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon
- (2009) Robin J. Prestwich et al. HUMAN GENE THERAPY
- Virus Binding to a Plasma Membrane Receptor Triggers Interleukin-1α-Mediated Proinflammatory Macrophage Response In Vivo
- (2009) Nelson C. Di Paolo et al. IMMUNITY
- IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer
- (2009) A. Andersson et al. JOURNAL OF IMMUNOLOGY
- The role of CXC chemokines and their receptors in cancer
- (2008) Jo Vandercappellen et al. CANCER LETTERS
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
- Orchestrating the orchestrators: chemokines in control of T cell traffic
- (2008) Shannon K Bromley et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started